ENTRY       D10156                      Drug
NAME        Romosozumab (USAN);
            Romosozumab (genetical recombination) (JAN);
            Romosozumab-aqqg;
            Evenity (TN)
PRODUCT     EVENITY (Amgen)
FORMULA     C6452H9926N1714O2040S54
EXACT_MASS  145785.0578
MOL_WEIGHT  145875.6186
CLASS       Musculo-skeletal system agent
             DG03232  Osteoporosis agent
REMARK      Therapeutic category: 3999
            ATC code: M05BX06
            Product: D10156<JP/US>
EFFICACY    Osteoporosis agent, Anti-Sclerostin monoclonal antibody
  DISEASE   Osteoporosis [DS:H01593]
  TYPE      Monoclonal antibody
COMMENT     Treatment of osteoporosis
TARGET      SOST [HSA:50964] [KO:K16834]
  PATHWAY   hsa04310(50964)  Wnt signaling pathway
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             M MUSCULO-SKELETAL SYSTEM
              M05 DRUGS FOR TREATMENT OF BONE DISEASES
               M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
                M05BX Other drugs affecting bone structure and mineralization
                 M05BX06 Romosozumab
                  D10156  Romosozumab (USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Metabolic Bone Disease Agents
              Sclerostin Inhibitors
               Romosozumab
                D10156  Romosozumab (USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D10156  Romosozumab (USAN); Romosozumab (genetical recombination) (JAN)
            Drug groups [BR:br08330]
             Musculo-skeletal system agent
              DG03232  Osteoporosis agent
               D10156  Romosozumab
            Drug classes [BR:br08332]
             Musculo-skeletal system agent
              DG03232  Osteoporosis agent
               D10156  Romosozumab
            Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Signaling molecules
               Wnt signaling
                SOST
                 D10156  Romosozumab (USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10156
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10156
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10156
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10156
DBLINKS     CAS: 909395-70-6
            PubChem: 135626874
///
